Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

AbbVie/Allergan's merger faces public opposition

AbbVie/Allergan's merger faces public opposition Allergan’s biggest product, Botox, is also facing tougher competition in the market from new migraine drugs and rivals in its medical aesthetics indications.

Strike three for Rova-T has AbbVie cutting its losses

Strike three for Rova-T has AbbVie cutting its losses In June it agreed to acquire Allergan in a  $63bn deal that adds $16bn in annual sales from products like wrinkle treatment Botox, diversifying its revenue stream.

AbbVie CEO Gonzalez defends Allergan takeover

AbbVie CEO Gonzalez defends Allergan takeover Richard Gonzalez. He downplayed the risks to Allergan’s Botox from branded rivals such as Evolus’ Jeuveau or biosimilars. ... reasons “it's highly unlikely that we would see a biosimilar against Botox for a long, long time, if ever.”.

AbbVie to acquire Allergan for $63bn

AbbVie to acquire Allergan for $63bn The company says the deal will significantly expand and diversify its revenue base with new therapeutic areas, including Allergan's leading medical aesthetics business, most notably Botox, which earned $3.7bn

CHMP nod for Alexion, GSK drugs, revocation for Lartruvo

CHMP nod for Alexion, GSK drugs, revocation for Lartruvo Nuceiva (botulinum toxin type a), a facial filler for vertical lines between the eyebrows, a new rival for Allergan’s Botox.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Why we need to improve diverse representation in clinical trials
Diversity in clinical trials: The powerful need to improve it! “One size fits all” is rapidly becoming an outdated concept in modern-day life, and medical research is no exception. Without...

Infographics